Produkty 80321-69-3

CAS 80321-69-3 występuje w naszej ofercie pod nazwami: Gypenoside xvii, 95%, Gypenoside XVII, Gypenoside XVII, Gypenoside XVII/ 99.76% (existing batch purity), Gypenoside XVII, 99.69%. Oferty producentów: Combi-blocks, TRC, GLPBio, TargetMol, Biosynth. Dostępne opakowania: 100mg, 1mg, 2,5mg, 5mg, 10mg, 25mg, 50mg, 10 mg.

Gypenoside xvii, 95%
Combi-blocks
  • opakowanie: 100mg
  • Warianty: 1
Zobacz produkt
Gypenoside XVII
TRC, Biosynth
  • opakowanie: 1mg, 2,5mg, 5mg, 25mg
  • Warianty: 7
Zobacz produkt
Gypenoside XVII
GLPBio
  • opakowanie: 10mg, 5mg
  • Warianty: 2
od 835,75
Zobacz produkt
Gypenoside XVII/ 99.76% (existing batch purity)
TargetMol
  • opakowanie: 1mg, 5mg, 10mg, 25mg
  • Warianty: 6
od 452,11
Zobacz produkt
Gypenoside XVII, 99.69%
MedChemExpress
  • opakowanie: 10 mg, 5 mg, 10mM/1mL
  • Warianty: 3
od 695,86
Zobacz produkt
Gypenoside XVII (Standard)
MedChemExpress
  • opakowanie: 1 mg, 10 mg, 25 mg, 100 mg
  • Warianty: 6
od 505,45
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-[[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[(2S)-2-[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-4,4,8,10,14-pentamethyl-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-methylhept-5-en-2-yl]oxyoxan-2-yl]methoxy]oxane-3,4,5-triol (CAS 80321-69-3) to związek chemiczny o wzorze sumarycznym C48H82O18 i masie molowej 947.2 g/mol. Nazwa systematyczna IUPAC: (2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-[[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[(2S)-2-[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-4,4,8,10,14-pentamethyl-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-methylhept-5-en-2-yl]oxyoxan-2-yl]methoxy]oxane-3,4,5-triol. InChIKey: ZRBFCAALKKNCJG-SJYBZOGZSA-N.

Dane identyfikacyjne
Wzór sumarycznyC48H82O18
Masa molowa947.2 g/mol
Nazwa IUPAC(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-[[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[(2S)-2-[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-4,4,8,10,14-pentamethyl-3-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-6-methylhept-5-en-2-yl]oxyoxan-2-yl]methoxy]oxane-3,4,5-triol
InChIKeyZRBFCAALKKNCJG-SJYBZOGZSA-N
SMILESCC(=CCC[C@@](C)([C@H]1CC[C@@]2([C@@H]1[C@@H](C[C@H]3[C@]2(CC[C@@H]4[C@@]3(CC[C@@H](C4(C)C)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)C)C)O)C)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)O)O)O)O)O)O)C

Dane obliczone przez PubChem (NCBI)

Synonimy: Gypenoside XVII, Gyp-17, GYPENOSIDE-XVII, Gynosaponin S, Ginsenoside XVII, Gypenoside XVIIGynosaponin S, orb1221775, orb3140444
Izomery (ten sam wzór sumaryczny)
(2S,3R,4R,5R,6S)-2-[(2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-4,4,8,10,14-pentamethyl-17-[(2S)-6-methyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhept-5-en-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy-6-methyloxane-3,4,5-triol C48H82O18
(2S,3R,4S,5S,6R)-2-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-[[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-4,4,8,10,14-pentamethyl-17-[(2S)-6-methyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhept-5-en-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol C48H82O18